Discover how clinical and regulatory strategies shape medtech success, from investment decisions to commercialization, as discussed at LSI USA ’24.
Success in medtech innovation requires more than groundbreaking technology. During a panel at LSI USA '24, Ivanny Franklin of NAMSA emphasized the pivotal role of clinical and regulatory strategies in shaping investment decisions and driving long-term outcomes. Joined by distinguished panelists - Auriel August of Santé Ventures, Edwin Lindsay of Compliance Solutions Life Sciences, Nir Goldenberg of Mayo Clinic Ventures, and Adam Saltman of NAMSA - Franklin explored how regulatory rigor and clinical diligence intersect with investment value. This blog is originally published here: https://www.lsiusasummit.com/n....ews/discover-how-cli
